NEW HOPE(SZ:000876) Xin Jing Bao·2025-05-07 04:18Core Viewpoint - The release of the China-themed special issue of "Allergy" highlights significant advancements in the treatment of allergic diseases through biologics, showcasing the contributions of Chinese scholars to the global allergy science community [1][2]. Group 1: Publication and Impact - The special issue features 32 articles authored by Chinese scholars, focusing on various fields including allergy science, rhinology, respiratory medicine, and dermatology [1]. - "Allergy," established in 1948, has an impact factor of 12.6 in 2023, making it one of the most prestigious journals in the field of allergy science and clinical immunology [1]. - The editor-in-chief, Cezmi Akdis, praised the academic achievements of Chinese scholars, noting their positive influence on the global allergy science field [1]. Group 2: Advances in Treatment - Biologics are identified as a promising direction for treating allergic diseases, with increasing clinical experience expected to benefit more patients with difficult-to-treat and severe conditions [2]. - A Chinese consensus document on the use of biologics for chronic rhinosinusitis with nasal polyps was published, providing authoritative guidance on patient selection, treatment protocols, and efficacy evaluation [2]. - The special issue also includes research on the mechanisms of asthma related to environmental pollution, gut microbiome dysbiosis, and drug allergies, contributing innovative insights to the global allergy discipline [2].